Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(100.0%)
3Total
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07241338Phase 4Not Yet Recruiting

Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity

Role: lead

NCT05416840Phase 4Not Yet Recruiting

Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension

Role: lead

NCT05409898Unknown

Screening for Masked Hypertension With Smart Wearable Devices (SMART)

Role: lead

NCT02940548Phase 4Terminated

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness

Role: lead

All 4 trials loaded